v3.25.4
Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Schedule of Investments [Line Items]    
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 25,377,756 23,601,566
Common stock, shares outstanding 25,377,756 23,601,566
Debt instrument interest rate 6.00% 6.00%
Debt instrument, maturity date Dec. 30, 2026  
Debt instrument effective interest rate 7.08% 6.48%
Debt instrument face amount $ 35,829,825 $ 44,667,400
Convertible Notes Payable [Member]    
Schedule of Investments [Line Items]    
Debt instrument interest rate 6.50% 6.50%
Debt instrument, maturity date Aug. 14, 2029  
Debt instrument effective interest rate 7.17% 7.06%
Debt instrument face amount $ 35,000,000 $ 30,000,000
Non Controlled Non Affiliate Investments [Member]    
Schedule of Investments [Line Items]    
Investment cost 219,216,145 234,601,314
Non Controlled Affiliate Investments [Member]    
Schedule of Investments [Line Items]    
Investment cost 21,609,640 20,605,400
Controlled Investments [Member]    
Schedule of Investments [Line Items]    
Investment cost 0 1,602,940
Investments [Member]    
Schedule of Investments [Line Items]    
Investment cost $ 240,825,785 $ 256,809,654